Apoptosis and carcinogenesis

European Journal of Cell Biology

Volumn 73, Issue 3, 1997, Pages 189-197

  Wyllie, Andrew H ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Apoptosis; Cancer; Caspase; Ceramide; Cytokines; Necrosis; Oncogenes

Indexed keywords

CERAMIDE; CYSTEINE PROTEINASE; CYTOKINE RECEPTOR; CYTOPLASM PROTEIN; CYTOSKELETON PROTEIN; DNA; FAS ANTIGEN; NUCLEAR PROTEIN; PROTEIN BCL 2; PROTEIN P53; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR;

APOPTOSIS; CARCINOGENESIS; CELL DAMAGE; CELL MEMBRANE; ENZYME ACTIVATION; MEMBRANE POTENTIAL; MITOCHONDRION; ONCOGENE; PRIORITY JOURNAL; PROTEIN DEGRADATION; REVIEW; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE;

PROTEA;

EID: 0030746401     PISSN: 01719335     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (107)

1. Arends, M.S., A. H. McGregor, N. J. Toft, E. J. H. Brown, A. H. Wyllie: Susceptibility to apoptosis is differentially regulated by U c-myc and mutated Ha-vas oncogenes and is associated with endonuclease availability. Br. J. Cancer 68, 1127-1133 (1993).
2. Bellamy, C. O. C., A. R. Clarke, A. H. Wyllie, D. J. Harrison: P53 deficiency in liver reduces local control of survival and proliferation but does not affect apoptosis after DNA damage. FASEB J. (in press) (1997).
3. Boise, L. H., M. Gonzalezgarcia, C. E. Postema, L. Y. Ding, T. Lindsten, L. A. Turks, X. H. Mao, G. Nuñez, C. B. Thompson: Bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74, 597-608 (1993).
4. Boldin, M., T. M. Goncharov, Y. V. Goltsev, D. Wallach: Involvement of MACH, a novel MORT 1/FADD-interacting protease, in Fas/ APO-1 and TNF receptor-induced cell death. Cell 85, 803-815 (1996).
5. Boyd, J. M., G. J. Galio, B. Elangovan, A. B. Houghton, S. Malstrom, B. J. Avery, R. G. Ebb, T. Subramanian, T. Ghilternden, R. J. Lutz, G. Chinnadurai: Bik, a novel death-inducing protein shares a distinct sequence motif with Bcl-2 family proteins and interacts with viral and cellular survival-promoting proteins. Oncogene 11, 1921-1928 (1995).
6. Boyd, J. M., S. Malstrom, T. Subramanian, L. K. Venkatesh, U. Schneper, B. Elangovan, D'Sa-Eipper, G. Chinnadurai: Adenovirus E1B 19kDa and bcl-2 proteins interact with a common set of cellular proteins. Cell 79, 341-351 (1994).
7. Canman, C. E., T. M. Gilmer, S. B. Coutts, M. B. Kastan: Growth factor modulation of p53-indicated growth arrest versus apoptosis. Genes Dev. 1, 600-611 (1995).
8. Castedo, M., T. Hirsch, S. A. Susin, N. Zamzami, P. Marchetti, A. Macho, G. Kroemer: Sequential acquisition of mitochondrial and plasma membrane alterations during early lymphogic apoptosis. J. Immunol. 15, 512-521 (1996).
9. Chapman, R. S., A. D. Whetton, C. Dive: The suppression of drug-induced apoptosis by activation of v-abc protein-tyrosine kinase. Cancer Res. 54, 5131-5137 (1994).
10. Cifone, M. G., R. DeMaria, R. P. Roncaioli, M. R. Rippo, M. Azuma, L. L. Laimer, A. Santoni, R. Testi: Apoptotic signalling through CD95 (Fas-Apo-1) activates an acidic sphingomyelinase. J. Exp. Med. 177, 1547-1552 (1994).
11. Clarke, A. R., S. Gledhill, M. L. Hooper, C. C. Bird, A. H. Wyllie: P53 dependence of early apoptotic and proliferative responses within the mouse intestinal epithelium following γ-irradiation. Oncogene 9, 1767-1773 (1994).
12. Clarke, A. R., L. A. Howard, D. J. Harrison, D. J. Winton: P53 mutation frequency and apoptosis in the murine small intestine. Oncogene (in press) (1997).
13. Clarke, A. R., E. R. Maandag, M. van Room, N. M. T. van der Lugt, M. van der Valk, M. L. Hooper, A. Berns, H. te Riele: Requirements for a functional Rb-1 gene in murine development. Nature 359, 328-330 (1992).
14. Clarke, A. R., C. A. Purdie, D. J. Harrison, R. G. Morris, C. C. Bird, M. L. Hooper, A. H. Wyllie: Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 362, 849-851 (1993).
15. Clem, R. J., J. M. Hardwick, L. K. Miller: Anti-apoptotic genes of baculoviruses. Cell Death & Differentiation 3, 9-16 (1996).
16. Cohen, O., E. Feinstein, A. Kimchi: DAP-kinase, is a Ca2+ calmodulin-dependent, cytoskeletal-associated protein kinase, with cell death-inducing functions that depend on its catalytic activity. EMBO J. 16, 998-1008 (1997).
17. Darmon, A. J., D. W. Nicholson, R. C. Bleackley: Activation of the apoptotic protease CPP32 by cytotoxic T-cell-derived granzyme B. Nature 377, 446-448 (1995).
18. Debbas, M., E. White: Wild type p53 mediates apoptosis by E1A which is inhibited by E1B. Genes Dev. 7, 546-554 (1993).
19. Deiss, L.P., H. Galinka, H. Berissi, O. Cohen, A. Kimchi: Cathepsin D protease mediates programmed cell death induced by interferon-γ, Fas/APO-1 and TNF-α. EMBO J. 15, 3861-3870 (1996).
20. Deiss, L. P., A. Kimchi: A genetic tool used to identify thioredoxin as a mediator of a growth inhibitory signal. Science 252, 117-120 (1991).
21. Evan, G. I., A. H. Wyllie, C. S. Gilbert, T. Littlewood, H. Land, M. Brooks, C. M. Waters, L. Z. Peun, C. L. Hancock: Induction of apoptosis in fibroblasts by c-myc protein. Cell 69, 119-128 (1992).
22. Farrow, S. N., R. Brown: New members of the Bcl-2 family and their protein partners. Curr. Opin. Genet. Dev. 6, 45-49 (1996).
23. Fernandes-Alnemri, T., G. Litwack, E. S. Alnemri: CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein ICE-3 and mammalian interleukin-1β-converting enzyme. J. Biol. Chem. 269, 30761-30764 (1994).
24. Fishel, R.: Genomic instability, mutators and the development of cancer: is there a role for p53? J. Natl. Cancer Inst. 88, 1608-1609 (1996).
25. Greenberg, A. H.: Activation of apoptosis pathways by granzyme B. Cell Death & Differentiation 3, 269-274 (1996).
26. Griffiths, S. D., A. R. Clarke, L. E. Healy, G. Ross, A. M. Ford, M. L. Hooper, A. H. Wyllie, M. Greaves: Absence of p53 promotes propagation of mutant cells following genotoxic damage. Oncogene 9, 603-609 (1997).
27. Gulbins, E., K. M. Coggeshall, B. Brenner, K. Schlottmann, O. Linderskamp, F. Lang: Fas-induced apoptosis is mediated by activation of a ras and rac protein-regulated signalling pathway. J. Biol. Chem. 271, 26389-26394 (1996).
28. Haimovitz-Friedman, A., N. A. Balabian, M. McLoughlin, D. Enleither, J. Michaeli, I. Vlodarsky, Z. Fuks: Protein kinase C mediates basic fibroblast growth factor production of endotrachial cells against radiation-induced apoptosis. Cancer Res. 54, 2591-2597 (1994).
29. Haimovitz-Friedman, A., C.-C. Kan, D. Enleiter, R. S. Persaid, M. McLoughlin, Z. Fuks, R. N. Kolesnick: Ionizing radiation acts on cellular membranes to generate ceramide and initiate apoptosis. J. Exp. Med. 180, 525-535 (1994).
30. Han, Z. Y., N. Malik, T. Carter, W. H. Reeves, J. H. Wyche, F. A. Hendrickson: DNA-dependent protein-kinase is a target for a CPP32-like apoptotic protease. J. Biol. Chem. 271, 25035-25040 (1996).
31. Hanun, Y.: Functions of ceramde in co-ordinating cellular responses to stress. Science 274, 1855-1859 (1996).
32. Harrington, E. A., M. R. Bennett, A. Fanidi, G. I. Evan: C-myc induced apoptosis in fibroblasts is inhibited by specific cytokines. EMBO J. 13, 3286-3295 (1994).
33. Hengartner, M. O.: Programmed cell death in invertebrates. Curr. Opin. Genet. Dev. 6, 34-38 (1996).
34. Hengartner, M. O., J. R. Horvitz: C. elegans survival gene ced-9 encodes a functional homologue of the mammalian proto-oncogene bcl-2. Cell 76, 665-676 (1994).
35. Hermeking, H., D. Eick: Mediation of c-myc induced apoptosis by p53. Science 265, 2091-2092 (1994).
36. Hockenbery, D. M., Z. N. Oltvai, X.-M. Yin, C. L. Milliman, S. J. Korsmeyer: Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 75, 241-251 (1993).
37. Howes, K. A., N. Ransom, D. S. Papermaster, J. G. H. Lasudry, D. M. Albert, J. J. Windle: Apoptosis or retinoblastoma: alternative fates of photoreceptors expressing the HPV-16 E7 gene in the presence or absence of p53. Genes Dev. 8, 1300-1310 (1994).
38. Itoh, N., S. Yonehara, A. Ishü, M. Yonehara, S. Mizushina, M. Sameshima, A. Hasu, Y. Seto, S. Nagata: The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66, 233-243 (1991).
39. Jacobson, M. D., M. C. Raff: Programmed cell death and bcl-2 protection in very low oxygen. Nature 374, 814-816 (1995).
40. Kauffmann-Zeh, A., P. Rodriguez-Viciani, E. Ulrich, C. Gilbert, P. Coffer, J. Downward, G. Evan: Suppression of c-myc-induced apoptosis by ras signalling through PI 3-kinase and PKB. Nature 385, 544-548 (1997).
41. Kemp, C. J., T. Wheldon, A. Balmain: P53-deficient mice are extremely susceptible to radiation-induced mutagenesis. Nat. Genet. 8, 66-69 (1994).
42. Kerr, J. F. R., A. H. Wyllie, A. R. Currie: Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer 26, 239-257 (1972).
43. Kissil, J. L., L. P. Deiss, M. Bayewitch, T. Raveh, G. Khaspekov, A. Kimchi: Isolation of DAP3, a novel mediator of interferon-γ-induced cell death. J. Biol. Chem. 270, 27932-27936 (1996).
44. Krammer, P. H., J. Dhein, H. Walezak, I. Behrmann, S. Mariani, B. Matiba, M. Fath, P. T. Daniel, E. Knipping, M. O. Westendorp, K. Stricker, C. Bäunder, S. Hellbardt, M. Germer, M. E. Peter, K.-M. Debatin: The role of APO-1-mediated apoptosis in the immune system. Immunol. Rev. 142, 175-191 (1994).
45. Kumar, S., M. F. Lavin: The ICE family of cysteine proteases as effectors of cell death. Cell Death & Differentiation 3, 255-267 (1996).
46. Lazebnik, Y. A., S. Cole, C. A. Cooke, W. G. Nelson, W. C. Earnshaw: Nuclear events of apoptosis in vitro in cell-free mitotic extracts: a model system for analysis of the active phase of apoptosis. J. Cell Biol. 123, 7-22 (1993).
47. Lazebnik, Y. A., S. H. Kaufmann, S. Desnoyers, G. G. Poirier, W. C. Earnshaw: Cleavage of poly (ADP-ribose) polymerase by a proteinase with properties like ICE. Nature 371, 346-347 (1994).
48. Lazebnik, Y. A., A. Takahashi, R. D. Moir, R. D. Goldman, G. G. Poirier, S. H. Kaufman, W. C. Earnshaw: Studies of the lamin protease reveal multiple parallel biochemical pathways during apoptotic execution. Proc. Natl. Acad. Sci. USA 92, 9042-9046 (1995).
49. Liu, H.-J. L., V. Eviner, G. C. Predegart, E. W. White: Activated H-ras rescues E1A-induced apoptosis and cooperates with E1A to overcome p53-dependent growth arrest. Mol. Cell. Biol. 15, 4535-4544 (1995).
50. Lowe, S. W., T. Jacks, D. E. Housman, H. E. Ruley: Abrogation of oncogene-associated apoptosis allows transformation of p53-deficient cells. Proc. Natl. Acad. Sci. USA 91, 2026-2030 (1994).
51. Lowe, S. W., H. E. Ruley, T. Jacks, D. E. Housman: P53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74, 957-967 (1993).
52. Lowe, S. W., E. M. Schmitt, S. W. Smith, B. A. Osborne, T. Jacks: p53 is required for radiation induced apoptosis in mouse thymocytes. Nature 362, 847-849 (1993).
53. Lui, X., C. N. Kim, J. Yang, R. Jenmerson, X. Wang: Induction of apoptotic programme in cell-free extracts: requirement for a dATP and cytochrome C. Cell 86, 147-157 (1996).
54. Martel, C., E. Batsché, F. Harper, C. Crémisi: Inactivation of retinoblastoma gene product RB or an RB-related protein by SV40 antigen in MDCK epithelial cells results in massive apoptosis. Cell Death & Differentiation 3, 285-298 (1996).
55. Martin, S. J., G. A. O'Brian, W. K. Nishioka, A. J. McGahon, A. Mahboubi, T. C. Saido, D. R. Green: Proteolysis of fodrin (non-erythroid spectrin) during apoptosis. J. Biol. Chem. 270, 6425-6428 (1995).
56. Mashima, T., M. Naito, S. Kataoka, H. Kawai, T. Tsumo: Aspartate-based inhibitor of interleukin-1β-converting enzyme prevents antitumor agent-induced apoptosis in human myeloid leukemia in 937 cells. Biochem. Biophys. Res. Comm. 209, 907-915 (1995).
57. Merritt, A. J., C. S. Potten, C. J. Kemp, J. A. Hickman, A. Balmain, D. P. Lane, P. A. Hall: The role of p53 in spontaneous and radiation-induced apoptosis in the gastrointestinal tract of normal and p53 deficient mice. Cancer Res. 54, 614-617 (1994).
58. Midgley, C. A., S. White, R. Howitt, V. Save, M. G. Dunlop, P. A. Hall, D. P. Lane, A. H. Wyllie, C. C. Bird: Ki-ras mutations in adenomas: a characteristic of cancer-bearing colorectal mucosa. J. Pathol. 180, 357-363 (1997).
59. Minn, A. J., C. M. Rudin, L. H. Boise, C. B. Thompson: Expression of bcl-xl can confer a multidrug resistance phenotype. Blood 86, 1903-1910 (1995).
60. Möller, P., K. Koretz, F. Leithanser, S. Brüderlein, C. Henne, A. Quentmeier, P. H. Krammer: Expression of APO-1 (CD95), a member of the NGF/TNF receptor super-family, in normal and neoplastic colon epithelium. Int. J. Cancer, 57, 371-377 (1994).
61. Mosialos, G., M. Birkenbach, R. Yalamanchili, T. Van Ardale, C. Ware, E. Kieff: The Epstein-Barr virus transforming protein LMP-1 engages signalling proteins for the tumor necrosis factor receptor family. Cell 80, 389-399 (1995).
62. Muchmore, S. W., M. Sattler, H. Liang, R. P. Meadows, J. E. Harlam, H. S. Yoon, D. Nettesheim, B. S. Chang, C. B. Thompson, S. L. Wong, S. I. Ng, S. W. Fesik: X-ray and NMR structure of human bcl-xl, an inhibitor of programmed cell death. Nature 381, 335-341 (1996).
63. Muzio, M., A. M. Chinnaiyan, F. L. Kischkel, R. O'Rourke, A. Sherchenko, J. Ni, C. Scaffidi, J. D. Bretz, M. Zhang, R. Gentz, M. Mann, P. H. Krammer, M. E. Peter, V. M. Dixit: FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signalling complex. Cell 85, 817-827 (1996).
64. Naik, P., J. Karrim, D. Hanahan: The rise and fall of apoptosis during multistage tumorigenesis: down-modulation contributes to tumor progression from angiogenic progenitors. Genes Dev. 10, 2105-2106 (1996).
65. Nguyen, M., P. E. Branton, P. A. Walton, Z. N. Oltvai, S. J. Korsmeyer, G. C. Shore: Role of membrane anchor domain of bcl-2 in suppression of apoptosis caused by EIB-defective adenovirus. J. Biol. Chem. 269, 165212-16524 (1994).
66. Nicholson, D. W., A. Ambereen, N. A. Thornberry, J. P. Vaillancourt, C. K. Ding, M. Gallant, Y. Gareau, P. R. Griffin, M. Labelle, Y. Lazebnik, N. A. Munday, S. M. Raju, M. E. Smulson, T.-T. Yaurin, V. L. Yu, D. K. Miller: Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 376, 37-43 (1995).
67. Nunß̃ez, G., M. F. Clarke: The Bcl-2 family of proteins: regulators of cell death and survival. Trends Cell Biol. 4, 399-403 (1994).
68. O'Reilly, M.S., L. Holmgren, C. Chew, J. Folkman: Angiostatin induces and sustains dormancy of human tumors in mice. Nature Med. 2, 689-692 (1996).
69. Obeid, L.M., C. M. Linardic, L. A. Karolak, Y. A. Hanun: Programmed cell death induced by ceramide. Science 259, 1769-1771 (1993).
70. Oehm, A., I. Behrmann, W. Falk, M. Pawhita, G. Maier, C. Klas, M. Li-Weber, S. Richards, J. Dhein, B. C. Tranth, C. H. Ponsting, P. H. Krammer: Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily. Sequence identity with the Fas antigen. J. Biol. Chem. 267, 10709-10715 (1992).
71. Pan, H., A. E. Griep: Altered cell cycle regulation in the lens of HPV-16 E6 or E7 transgenic mice: implications for tumor suppressor gene function in development. Genes Dev. 8, 1285-1299 (1994).
72. Peitsch, M. C., H. G. Mannherz, J. Tschopp: The apoptosis endonuclease: clearing up after cell death? Trends Cell Biol. 4, 37-41 (1994).
73. Peter, M. E., F. C. Kischker, S. Hellbardt, A. M. Chinnaiyan, P. H. Krammer, V. M. Dixit: CD95 (APO-1/Fas)-associated signalling proteins. Cell Death & Differentiation 3, 161-170 (1996).
74. Purdie, C. A., D. J. Harrison, A. Peter, L. Dobbie, S. White, S. T. M. Holoic, D. M. Salter, C. C. Bird, A. H. Wyllie, M. L. Hooper, A. R. Clarke: Tumour incidence, spectrum and ploidy mice with a large deletion in the p53 gene. Oncogene 9, 603-609 (1994).
75. Reipert, S., B. M. Reipert, J. A. Hickman, T. D. Allen: Nuclear pore clustering is a consistent feature of apoptosis in vitro. Cell Death & Differentiation 3, 131-139 (1996).
76. Rouvier, E., M. F. Luciani, P. Golstein: Fay involvement in Ca(2+)-independent T cell-mediated cytotoxicity. J. Exp. Med. 177, 195-200 (1993).
77. Saenz-Robles, M. T., H. Symonds, J. Chew, T. van Dyke: Induction versus progression of brain tumor development: differential functions for the pRB and p53 targeting domains of simian virus 40 TAg1. Mol. Cell. Biol. 14, 2686-2698 (1994).
78. Santana, P., L. A. Peña, A. Haimovitz-Friedman, S. Martin, D. Green, M. McLaughlin. C. Cordon-Carlo, E. H. Schuchman, Z. Fuks, R. Kolesnick: Acid sphingomyelinase deficient lymphoblasts and mice are defective in radiation-induced apoptosis. Cell 86, 189-199 (1996).
79. Scheffner, M., J. M. Huibregtse, R. D. Vierstra, P. M. Howley: The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell 75, 495-505 (1993).
80. Shen, Y. T. E. Shenk: Viruses and apoptosis. Curr. Opin. Genet. Dev. 5, 105-111 (1995).
81. Shi, L., R. P. Kraut, R. Aebersold, A. H. Greenberg: A natural killer cell granule protein that induces DNA fragmentation and apoptosis. J. Exp. Med. 175, 553-566 (1992).
82. Shimizu, S., Y. Eguchi, H. Kosaka, W. Kamiike, H. Matsuda, Y. Tsujimoto: Prevention of hypoxia-induced cell death by bcl-2 and bcl-XL. Nature 374, 811-813 (1995).
83. Shimizu, S., Y. Eguchi, W. Kamiike, S. Waguri, Y. Uchiyama, H. Matsuda, Y. Tsiyimoto: Bcl-2 blocks loss of mitochondrial membrane potential while ICE inhibitors act at a different step during inhibition of death induced by respiratory chain inhibitors. Oncogene 13, 21-29 (1996).
84. Slebos, R. J., M. H. Lee, B. S. Plunkett, T. D. Kessis, B. O. Williams, T. Jacks, L. Hedrick, M.B. Kastan, T. Chok: P53-dependent G1 arrest involves prb-related proteins and is disrupted by the human papillomavirus 16 E7 oncoprotein. Proc. Natl. Acad. Sci. USA 91, 5320-5324 (1994).
85. Takahashi, A., W. C. Earnshaw: ICE-related proteases in apoptosis. Curr. Opin. Genet. Dev. 6, 50-55 (1996).
86. Takayama, S., T. Sato, S. Krajewski, K. Kochel, S. Irie, J. A. Millan, J. C. Reed: Cloning and functional analysis of Bag-1: a novel bcl-2 binding protein with anti-cell death activity. Cell 80, 279-284 (1995).
87. Tamura, T., M. Ishihara, M. S. Lamphier, N. Tanaka, I. Oishi, S. Aizawa, T. Matsuyama, T. W. Mak, S. Taki, T. Tamiguchi: An IRF-1-dependent pathway of DNA damage-induced apoptosis in mitogen-activated T lymphocytes. Nature 376, 596-599 (1995).
88. Tanaka, N., M. Ishihara, M. S. Lamphier, H. Nozaira, T. Matsuyama, T. W. Mak, S. Aizawa, T. Tokino, M. Oren, T. Tamiguchi: Cooperation of the tumour suppressors IRF-1 and p53 in response to DNA damage. Nature 382, 816-818 (1996).
89. Tanaka, S., K. Saito, J. C. Reed: Structure-function analysis of the Bcl-2 oncoprotein. J. Biol. Chem. 268, 10920-10926 (1993).
90. Tepper, C. G., S. Jayader, B. Liu, A. Bielawska, R. Wolff, S. Yonehara, Y. A. Hanun, M. F. Seldin: Role for ceramide as an endogenous mediator of fas-induced cytotoxicity. Proc. Natl. Acad. Sci. USA 92, 8443-8447 (1995).
91. Teraoka, H., Y. Yumoto, F. Watanabe, K. Tsukuda, A. Suva, M. Enari, S. Nagata: Cpp32/YAMA/Apopain cleaves the catalytic component of DNA-dependent protein kinase in the holoenzyme. FEBS Lett. 393, 1-6 (1996).
92. Tewari, M., L. T. Quan, K. O'Rourke, S. Desnoyers, Z. Zeng, D. R. Beidler, G. G. Poirier, G. S. Salvesen, V. M. Dixit: Yama/CPP32b, a mammalian homologue of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly-(ADP-ribose) polymerase. Cell 81, 801-809 (1995).
93. Trauth, B. C., C. Klas, A. M. J. Paters, S. Matzku, P. Möller, W. Falk, K.-M. Debatin, P. H. Krammer: Monoclonal antibody mediated tumor regression by induction of apoptosis. Science 245, 301-305 (1989).
94. Westwick, J. K., A. E. Bielawska, G. Dbaibo, Y. A. Hanun, D. A. Brenner: Ceramide activates the stress-activated protein kinases. J. Biol. Chem. 270, 22689-22692 (1995).
95. White, A. F., E. M. Livanos, T. D. Tlsty: Differential disruption of genomic integrity and cell cycle regulation in normal human fibroblasts by the HPV oncoproteins. Genes Dev. 8, 666-677 (1994).
96. White, E.: Life, death and the pursuit of apoptosis. Genes Dev. 10, 1-15 (1996).
97. White, K., E. Tahaoglu, H. Steller: Cell killing by the Drosophila gene reaper. Science 271, 805-807 (1996).
98. Whyte, M.: ICE/CED-3 proteases in apoptosis. Trends Cell Biol. 6, 245-248 (1996).
99. Wiegmann, K., S. Schutze, T. Machleidt, D. Witte, M. Kronke: Functional dichotomy of neutral and acid sphingomyelinases in tumour necrosis factor signalling. Cell 78, 1005-1015 (1994).
100. Wright, S. C., Q. S. Wei, J. Zhong, H. Zheng, D. H. Kinder, J. W. Larrick: Purification of a 24-kD protease from apoptosis tumor-cells that activates DNA fragmentation. J. Exp. Med. 180, 2113-2123 (1994).
101. Wu, X., A. J. Levine: P53 and E2F cooperate to mediate apoptosis. Proc. Natl. Acad. Sci. USA 91, 3602-3606 (1994).
102. Wyllie, A. H., J. F. R. Kerr, A. R. Currie: Cell Death: The significance of apoptosis. Int. Rev. Cytol. 68, 251-306 (1980).
103. Wyllie, A. H., P. J. Carder, A. R. Clarke, K. J. Cripps, S. Gledhill, M. F. Greaves, S. Griffiths, D. J. Harrison, M. L. Hooper, R. G. Morris, C. A. Purdie, C. C. Bird: Apoptosis in carcinogenesis: the role of p53. Cold Spring Harbor Symp. Quant. Biol. 59, 403-409 (1994).
104. Wyllie, A. H.: Glucocorticoid-induced apoptosis is associated with endogenous endonuclease activation. Nature 284, 555-556 (1980).
105. Xia, Z., M. Dickens, J. Raingeaud, R. J. Davis, M. Greenberg: Opposing effects of SEK and JNK-p38 MAP kinases on apoptosis. Science 270, 1326-1331 (1995).
106. Yonish-Rouach, E., D. Resnitsky, J. Lotem, L. Sachs, A. Kimchi, M. Oren: Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature 352, 345-347 (1991).
107. Yuan, J. Y., S. Shaham, S. Ledoux, H. M. Ellis, H. R. Horvitz: The C. elegans cell death gene ced-3 encodes apoptosis similar to mammalian interleukin-1β-converting enzyme. Cell 75, 641-652 (1993).